Maccabi Tel Aviv Ownership Dispute Escalates Amidst Sharp Accusations
The battle for control of the Maccabi Tel Aviv basketball club has intensified, with businessman Richard Daiz launching a scathing response to a joint statement by Chairman Shimon Mizrahi and Udi Recanati. Daiz, who holds a stake in the team, vehemently denied allegations of concealing judicial decisions and asserted that the arbitration process is only beginning.
Daiz's statement addressed a recent court decision that rejected his request for a temporary injunction. He acknowledged this as the sole undisputed fact in Mizrahi and Recanati's announcement, but emphasized that the court opted to defer the resolution to a formal arbitration process as stipulated in the shareholders' agreement. According to Daiz, the court also ruled that any recent actions taken by Mizrahi and Recanati concerning the club's shares would be subject to the arbitration appeal, and prohibited them from taking further steps without prior notice.
Daiz dismissed the accusations of withholding court decisions, labeling his partners' statement as "shameful to them and the club." He pointed out that he issued his official statement before the court's ruling, implying he could not have known its outcome. Daiz further stated that the joint announcement exemplifies flawed norms within the club, which he intends to fundamentally change.
Concluding his remarks, Daiz delivered a pointed message about Maccabi Tel Aviv's organizational culture and his future approach. He stressed that accepting truth, even when unpleasant, and avoiding the blame of others are crucial for building a strong, long-term organization. He believes this is the only way to restore the club to its rightful place and pledged to continue working fearlessly for Maccabi Tel Aviv's future.
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.